Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodilatory effects of nitric oxide

FASEB Journal

Volumn 19, Issue 6, 2005, Pages 602-604

  Brouet, Agnès ^a   DeWever, Julie ^a   Martinive, Philippe ^a   Havaux, Xavier ^a   Bouzin, Caroline ^a   Sonveaux, Pierre ^a   Feron, Olivier ^a,b  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^b Unit of Pharmacology and Therapeutics   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; COMPLEMENTARY DNA; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; RECOMBINANT CAVEOLIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DNA TRANSFECTION; ENDOTHELIUM CELL; GENE DELIVERY SYSTEM; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR BLOOD FLOW; TUMOR GROWTH; TUMOR VASCULARIZATION; VASODILATATION;

ANIMALS; CARBACHOL; CELL MOVEMENT; DRUG INTERACTIONS; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; MICE; MICE, INBRED C57BL; MICROCIRCULATION; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; RECOMBINANT PROTEINS; TRANSFECTION; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASODILATION;

EID: 16344373044     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.04-2682fje     Document Type: Article

References (0)